BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15386797)

  • 21. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
    Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
    Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The diagnostic value of urinary cytology in patients with bladder carcinoma.
    Schoonees R; Gamarra MG; Moore RH; Murphy GP
    J Urol; 1971 Nov; 106(5):693-6. PubMed ID: 5115726
    [No Abstract]   [Full Text] [Related]  

  • 23. Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers.
    Lokeshwar VB; Habuchi T; Grossman HB; Murphy WM; Hautmann SH; Hemstreet GP; Bono AV; Getzenberg RH; Goebell P; Schmitz-Dräger BJ; Schalken JA; Fradet Y; Marberger M; Messing E; Droller MJ
    Urology; 2005 Dec; 66(6 Suppl 1):35-63. PubMed ID: 16399415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surveillance of patients with bladder carcinoma using fluorescent in-situ hybridization on bladder washings.
    Bergman J; Reznichek RC; Rajfer J
    BJU Int; 2008 Jan; 101(1):26-9. PubMed ID: 17850364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study on the diagnosis of urothelial cancer using multi-colour fluorescence in situ hybridization (FISH)--comparative analysis between FISH and cytology].
    Onishi T; Ichikawa T; Igarashi T
    Hinyokika Kiyo; 2008 Apr; 54(4):253-6. PubMed ID: 18516915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary NMP22 BladderChek test in the diagnosis of superficial bladder cancer.
    Moonen PM; Kiemeney LA; Witjes JA
    Eur Urol; 2005 Dec; 48(6):951-6; discussion 956. PubMed ID: 16257108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is conventional urinary cytology still reliable for diagnosis of primary bladder carcinoma? Accuracy based on data linkage of a consecutive clinical series and cancer registry.
    Turco P; Houssami N; Bulgaresi P; Troni GM; Galanti L; Cariaggi MP; Cifarelli P; Crocetti E; Ciatto S
    Acta Cytol; 2011; 55(2):193-6. PubMed ID: 21325806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [FISH and thin layer in urinary cytology].
    Paglierani M; Castiglione F; Garbini F; Buccoliero AM; Raspollini MR; Lapini A; Vignolini G; Taddei GL
    Pathologica; 2005 Aug; 97(4):200. PubMed ID: 16440661
    [No Abstract]   [Full Text] [Related]  

  • 29. Urinary cytology: the subjective diagnostic clues and their evaluation by computer.
    Koss LG
    Anal Quant Cytol; 1979; 1(3):202-6. PubMed ID: 396840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: a prospective study with focus on the natural history of anticipatory positive findings.
    Yoder BJ; Skacel M; Hedgepeth R; Babineau D; Ulchaker JC; Liou LS; Brainard JA; Biscotti CV; Jones JS; Tubbs RR
    Am J Clin Pathol; 2007 Feb; 127(2):295-301. PubMed ID: 17210520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The value of urinary cytology in vesical carcinoma].
    Netto Júnior NR; Hernandez AJ; Lemos GC; França LC
    AMB Rev Assoc Med Bras; 1981 Jul; 27(7):200-2. PubMed ID: 6977152
    [No Abstract]   [Full Text] [Related]  

  • 32. The value of the ImmunoCyt/uCyt+ test in the detection and follow-up of carcinoma in situ of the urinary bladder.
    Mian C; Lodde M; Comploj E; Palermo S; Mian M; Maier K; Pycha A
    Anticancer Res; 2005; 25(5):3641-4. PubMed ID: 16101194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
    Bowles L; Bialkowska-Hobrzanska H; Bukala B; Nott L; Razvi H
    Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytomorphology of urothelial carcinomatous peritoneal effusion.
    Xiao GQ
    Cytopathology; 2008 Apr; 19(2):131-3. PubMed ID: 18241206
    [No Abstract]   [Full Text] [Related]  

  • 35. Qualitative and quantitative assessment of urinary cytokeratin 8 and 18 fragments compared with voided urine cytology in diagnosis of bladder carcinoma.
    Hakenberg OW; Fuessel S; Richter K; Froehner M; Oehlschlaeger S; Rathert P; Meye A; Wirth MP
    Urology; 2004 Dec; 64(6):1121-6. PubMed ID: 15596183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exfoliative cytology of the urine in tumour diagnosis.
    Puntala P; Koivuniemi A; Sivula A
    Ann Chir Gynaecol Fenn; 1969; 58(1):20-3. PubMed ID: 5392146
    [No Abstract]   [Full Text] [Related]  

  • 37. Should molecular technology replace urine cytology?
    Sangar VK; Ramani VA; George NJ
    BJU Int; 2008 Nov; 102(10):1361. PubMed ID: 18710452
    [No Abstract]   [Full Text] [Related]  

  • 38. Urine cytology after flexible cystoscopy.
    Hyder Z
    BJU Int; 2006 Feb; 97(2):414-5; author reply 415. PubMed ID: 16430658
    [No Abstract]   [Full Text] [Related]  

  • 39. Slit-scan cytofluorometry. Basis for automated prescreening of urinary tract cytology.
    Cambier MA; Christy WJ; Wheeless LL; Frank IN
    J Histochem Cytochem; 1976 Jan; 24(1):305-7. PubMed ID: 1254926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 9p21 index as estimated by dual-color fluorescence in situ hybridization is useful to predict urothelial carcinoma recurrence in bladder washing cytology.
    Kawauchi S; Sakai H; Ikemoto K; Eguchi S; Nakao M; Takihara H; Shimabukuro T; Furuya T; Oga A; Matsuyama H; Takahashi M; Sasaki K
    Hum Pathol; 2009 Dec; 40(12):1783-9. PubMed ID: 19733894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.